PDB-code
Browse kinase entries (page 82 of 282)
First 78 79 80 PreviousLast86 85 84 Next| # | Kinase | Family | Group | PDB | Chain | (Alternate) Model | Orthosteric ligand | Organism | Details | File |
|---|---|---|---|---|---|---|---|---|---|---|
 | CSNK2A1 (CK2a1) | CK2 | CMGC | 6hbn | B | A | 5-propan-2-yl-4-prop-2-enoxy-7,8-dihydro-6~{h}-indeno[1,2-b]indole-9,10-dione | Human | Show |  |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hbn | B | B | 5-propan-2-yl-4-prop-2-enoxy-7,8-dihydro-6~{h}-indeno[1,2-b]indole-9,10-dione | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hme | A | A | 5-propan-2-yl-4-prop-2-enoxy-7,8-dihydro-6~{h}-indeno[1,2-b]indole-9,10-dione | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hme | A | B | 5-propan-2-yl-4-prop-2-enoxy-7,8-dihydro-6~{h}-indeno[1,2-b]indole-9,10-dione | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hme | B | A | 5-propan-2-yl-4-prop-2-enoxy-7,8-dihydro-6~{h}-indeno[1,2-b]indole-9,10-dione | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hme | B | B | 5-propan-2-yl-4-prop-2-enoxy-7,8-dihydro-6~{h}-indeno[1,2-b]indole-9,10-dione | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hnw | A | A | coumestrol | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hnw | A | B | coumestrol | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hny | A | A | boldine | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hny | A | B | boldine | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hop | A | A | 3-(4-hydroxy-3-methoxyphenyl)-2-propenoic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hop | A | B | 4-hydroxy-3-methoxybenzaldehyde | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hop | A | C | (~{e})-4-(3-methoxy-4-oxidanyl-phenyl)but-3-en-2-one | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hop | A | D | (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enal | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hoq | A | A | 3-(4-hydroxy-3-methoxyphenyl)-2-propenoic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hoq | A | B | 3-(4-hydroxy-3-methoxyphenyl)-2-propenoic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hor | A | A | (~{e})-4-(3-methoxy-4-oxidanyl-phenyl)but-3-en-2-one | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hor | A | B | (~{e})-4-(3-methoxy-4-oxidanyl-phenyl)but-3-en-2-one | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hot | A | A | (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enal | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hot | A | B | (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enal | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hou | A | A | 4-hydroxy-3-methoxybenzaldehyde | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6hou | A | B | 4-hydroxy-3-methoxybenzaldehyde | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6jwa | A | (2r,3r,4s,5r)-2-(4-amino-5-iodo-7h-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6l1z | A | (6ar)-3,4,6a,10-tetrakis(oxidanyl)-6,7-dihydroindeno[2,1-c]chromen-9-one | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6l21 | A | (6ar)-3,4,6a,10-tetrakis(oxidanyl)-6,7-dihydroindeno[2,1-c]chromen-9-one | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6l22 | A | A | (6ar)-3,4,6a,10-tetrakis(oxidanyl)-6,7-dihydroindeno[2,1-c]chromen-9-one | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6l22 | A | B | (6ar)-3,4,6a,10-tetrakis(oxidanyl)-6,7-dihydroindeno[2,1-c]chromen-9-one | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6l23 | A | A | (6ar)-3,4,6a,10-tetrakis(oxidanyl)-6,7-dihydroindeno[2,1-c]chromen-9-one | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6l23 | A | B | (6ar)-3,4,6a,10-tetrakis(oxidanyl)-6,7-dihydroindeno[2,1-c]chromen-9-one | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6l24 | A | A | (6ar)-3,4,6a,10-tetrakis(oxidanyl)-6,7-dihydroindeno[2,1-c]chromen-9-one | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6l24 | A | B | (6ar)-3,4,6a,10-tetrakis(oxidanyl)-6,7-dihydroindeno[2,1-c]chromen-9-one | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6q38 | A | A | benzoic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6q38 | A | B | benzoic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6q4q | A | A | benzoic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6q4q | A | B | benzoic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6q4q | A | C | benzoic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6q4q | B | A | benzoic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6q4q | B | B | benzoic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6q4q | B | C | benzoic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6qy7 | A | A | 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6qy7 | A | B | 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6qy7 | B | A | 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6qy7 | B | B | 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6rb1 | A | A | (~{e})-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)-~{n}-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6rb1 | A | B | (~{e})-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)-~{n}-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6rcb | A | (~{e})-2-cyano-~{n}-(2-hydroxyphenyl)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6rcm | A | A | (~{e})-~{n}-(5-~{tert}-butyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6rcm | A | B | (~{e})-~{n}-(5-~{tert}-butyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6rfe | A | A | (~{e})-~{n}-(5-bromanyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6rfe | A | B | (~{e})-~{n}-(5-bromanyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide | Human | Show | |
